Discover 1,431 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,431
Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study
for
Tinea Unguium, Onychomycosis
Location: Saint Petersburg FL
Sponsor: William N Handelman
Sex: All
Age: 21 - 70+
Code: NCT04341402
Phase 2, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: St. Petersburg FL, Tampa FL, Brandon FL, Sarasota FL,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)
for
Obstructive Sleep Apnea
Location: St. Petersburg FL, Dallas TX
Sponsor: ApniCure, Inc.
Sex: All
Age: 18+
Code: NCT01683721
Recruiting
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
for
Non Alcoholic Steatohepatitis (NASH)
Location: Pinellas Park FL, Clearwater FL, Bradenton FL, Ocoee FL,
Sponsor: Axcella Health, Inc
Sex: All
Age: 18+
Code: NCT04880187
Phase 2, Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Location: St. Petersburg FL, Tampa FL, Lakeland FL, Orlando FL,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy
Location: St. Petersburg FL, Gainesville FL, Stuart FL, Ladson SC,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07215234
Phase 1, Phase 2, Recruiting
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
for
Atopic Dermatitis
Location: Saint Petersburg FL, Orange City FL, Saint Augustine FL,
Sponsor: ASLAN Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05694884
Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: St. Petersburg FL, Durham NC, Nashville TN, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase 2, Recruiting
PEN-866 in Patients With Advanced Solid Malignancies
for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Saint Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Tarveda Therapeutics
Sex: All
Age: 18+
Code: NCT03221400
Phase 1, Phase 2, Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
for
Moderate-to-Severe Atopic Dermatitis
Location: St. Petersburg FL, Tampa FL, Boca Raton FL, Macon GA,
Sponsor: Nektar Therapeutics
Sex: All
Age: 12+
Code: NCT07690371
Phase 3, Recruiting
Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
for
Drug; Withdrawal Symptoms, Neonatal, Withdrawal,
Location: St Petersburg FL
Sponsor: Gauda, Estelle B., M.D.
Sex: All
Age: 0
Code: NCT02249026
Phase 1, Phase 2, Recruiting
Active & Responsive
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
for
Obesity, Overweight, Obstructive Sleep Apnoea
Location: Bradenton FL, Naples FL, West Palm Beach FL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07571109
Phase 3, Recruiting
Active & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Riverview FL, Orlando FL, Jacksonville FL, Hollywood FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
for
Mid Face Volume Deficit
Location: Bradenton FL, Coral Gables FL, Atlanta GA,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT06734351
Phase 3, Recruiting
Active & Responsive
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Location: Tampa FL, Weston FL, Fort Lauderdale FL, Augusta GA,
Sponsor: Procyrion
Sex: All
Age: 21+
Code: NCT05677100
Not recruiting
Active & Responsive
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
for
Overweight, Obesity
Location: Tampa FL, Fort Myers FL, Delray Beach FL, Birmingham AL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07770841
Phase 3, Recruiting
Active & Responsive
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
for
Obesity, Heart Failure
Location: Clearwater FL, Tampa FL, Safety Harbor FL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07567001
Phase 3, Recruiting
Active & Responsive
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
for
Bipolar I Disorder, Bipolar II Disorder
Location: Largo FL, Orlando FL, Gainesville FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06696755
Phase 2, Recruiting
Active & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Largo FL, Orlando FL, Maitland FL, Jacksonville FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase 2, Recruiting
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors